Liping Yang

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates comprising sting agonists
- Patent number 12,156,870
- Issue date Dec 3, 2024
- Mersana Therapeutics, Inc.
- Jeremy R. Duvall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purine inhibitors of human phosphatidylinositol 3-kinase delta
- Patent number 9,938,281
- Issue date Apr 10, 2018
- Merck Sharp & Dohme Corp.
- Abdelghani Abe Achab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,6,7 substituted purines as HDM2 inhibitors
- Patent number 9,682,978
- Issue date Jun 20, 2017
- Merck Sharp & Dohme Corp.
- Matthew P. Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyrimidines as HDM2 inhibitors
- Patent number 9,637,493
- Issue date May 2, 2017
- Merck Sharp & Dohme Corp.
- Christopher Dinsmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,6,7,8 substituted purines as HDM2 inhibitors
- Patent number 9,540,377
- Issue date Jan 10, 2017
- Merck Sharp & Dohme Corp.
- Carolyn Michele Cammarano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
- Patent number 9,227,971
- Issue date Jan 5, 2016
- Merck Sharp & Dohme Corp.
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for inhibiting KSP kinesin activity
- Patent number 8,796,460
- Issue date Aug 5, 2014
- Mercky Sharp & Dohme Corp.
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 8,569,336
- Issue date Oct 29, 2013
- Ling Tong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 8,541,572
- Issue date Sep 24, 2013
- Merck Sharp & Dohme Corp.
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS
- Publication number 20230321048
- Publication date Oct 12, 2023
- MERSANA THERAPEUTICS, INC.
- Jeremy R. DUVALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS
- Publication number 20230172910
- Publication date Jun 8, 2023
- MERSANA THERAPEUTICS, INC.
- Jeremy R. DUVALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIMERIC COMPOUNDS AS STING AGONISTS
- Publication number 20230074558
- Publication date Mar 9, 2023
- MERSANA THERAPEUTICS, INC.
- Jeremy R. DUVALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS
- Publication number 20220378749
- Publication date Dec 1, 2022
- MERSANA THERAPEUTICS, INC.
- Jeremy R. DUVALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES
- Publication number 20220305127
- Publication date Sep 29, 2022
- MERSANA THERAPEUTICS, INC.
- Joshua D. THOMAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
- Publication number 20160207926
- Publication date Jul 21, 2016
- MERCK SHARP & DOHME CORP.
- Abdelghani Abe Achab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS
- Publication number 20150368247
- Publication date Dec 24, 2015
- MERCK SHARP & DOHME CORP.
- Matthew P. Christopher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS
- Publication number 20150353553
- Publication date Dec 10, 2015
- MERCK SHARP & DOHME CORP.
- Carolyn Michele Cammarano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINES AS HDM2 INHIBITORS
- Publication number 20150329548
- Publication date Nov 19, 2015
- MERCK SHARP & DOHME CORP.
- Christopher Dinsmore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
- Publication number 20120322791
- Publication date Dec 20, 2012
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20120015926
- Publication date Jan 19, 2012
- Ling Tong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20120010181
- Publication date Jan 12, 2012
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY
- Publication number 20110171172
- Publication date Jul 14, 2011
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY
- Publication number 20110150757
- Publication date Jun 23, 2011
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY
- Publication number 20110123435
- Publication date May 26, 2011
- M. Arshad Siddiqui
- C07 - ORGANIC CHEMISTRY

Liping Yang

Person

Patents Grantslast 30 patents

Antibody drug conjugates comprising sting agonists

Purine inhibitors of human phosphatidylinositol 3-kinase delta

2,6,7 substituted purines as HDM2 inhibitors

Substituted pyrrolopyrimidines as HDM2 inhibitors

2,6,7,8 substituted purines as HDM2 inhibitors

Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors

Compounds for inhibiting KSP kinesin activity

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Patents Applicationslast 30 patents

ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS

ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS

DIMERIC COMPOUNDS AS STING AGONISTS

ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS

PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES

PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS

2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS

SUBSTITUTED PYRROLOPYRIMIDINES AS HDM2 INHIBITORS

PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY

COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY

COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY